André T. Brunetto

1.6k total citations
58 papers, 1.2k citations indexed

About

André T. Brunetto is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, André T. Brunetto has authored 58 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Molecular Biology, 23 papers in Oncology and 18 papers in Pulmonary and Respiratory Medicine. Recurrent topics in André T. Brunetto's work include Histone Deacetylase Inhibitors Research (13 papers), Protein Degradation and Inhibitors (11 papers) and Neuroblastoma Research and Treatments (9 papers). André T. Brunetto is often cited by papers focused on Histone Deacetylase Inhibitors Research (13 papers), Protein Degradation and Inhibitors (11 papers) and Neuroblastoma Research and Treatments (9 papers). André T. Brunetto collaborates with scholars based in Brazil, United Kingdom and United States. André T. Brunetto's co-authors include Johann S. de Bono, Rafael Roesler, David Olmos, Caroline Brunetto de Farias, Algemir Lunardi Brunetto, Lucas Vieira dos Santos, André Deeke Sasse, João Paulo da Silveira Nogueira Lima, Fabrício Henrique Pereira De Souza and Jorge Barriuso and has published in prestigious journals such as Journal of Clinical Oncology, JNCI Journal of the National Cancer Institute and Radiology.

In The Last Decade

André T. Brunetto

55 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
André T. Brunetto Brazil	20	515	451	266	174	122	58	1.2k
Beverly L. Falcón United States	16	804 1.6×	435 1.0×	216 0.8×	339 1.9×	68 0.6×	34	1.4k
Vito Longo Italy	23	467 0.9×	372 0.8×	130 0.5×	151 0.9×	77 0.6×	38	1.1k
R. K. Jain India	11	525 1.0×	557 1.2×	133 0.5×	226 1.3×	100 0.8×	30	1.2k
Giorgia Migliardi Italy	18	515 1.0×	719 1.6×	352 1.3×	277 1.6×	48 0.4×	28	1.3k
Fabienne Baffert Switzerland	13	968 1.9×	434 1.0×	223 0.8×	341 2.0×	92 0.8×	19	1.5k
Mayshan Ghiassi United States	11	1.2k 2.2×	566 1.3×	178 0.7×	216 1.2×	203 1.7×	13	1.7k
Derya Duranyıldız Türkiye	22	603 1.2×	662 1.5×	234 0.9×	294 1.7×	80 0.7×	85	1.4k
Pierre Bohanes United States	16	350 0.7×	592 1.3×	266 1.0×	205 1.2×	66 0.5×	52	1.0k
Klaus J. Schmitz Germany	22	514 1.0×	401 0.9×	261 1.0×	297 1.7×	109 0.9×	51	1.4k
Marilyn M. Giacomini United States	7	340 0.7×	247 0.5×	206 0.8×	82 0.5×	139 1.1×	8	1.0k

Countries citing papers authored by André T. Brunetto

Since Specialization

Citations

This map shows the geographic impact of André T. Brunetto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by André T. Brunetto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites André T. Brunetto more than expected).

Fields of papers citing papers by André T. Brunetto

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by André T. Brunetto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by André T. Brunetto. The network helps show where André T. Brunetto may publish in the future.

Co-authorship network of co-authors of André T. Brunetto

This figure shows the co-authorship network connecting the top 25 collaborators of André T. Brunetto. A scholar is included among the top collaborators of André T. Brunetto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with André T. Brunetto. André T. Brunetto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Rosé, Adriana, Lauro José Gregianin, Érica Boldrini, et al.. (2025). Results of the Latin American Pediatric Oncology Group (GALOP) Trial for Patients With Metastatic Ewing Sarcoma: Multicentric Study of Interval‐Compressed Multiagent and Metronomic Chemotherapy. Pediatric Blood & Cancer. 72(7). e31707–e31707.

Herlinger, Alice Laschuk, Marcelo A. C. Fernandes, Carolina Nör, et al.. (2025). Modulation of Stemness and Differentiation Regulators by Valproic Acid in Medulloblastoma Neurospheres. Cells. 14(2). 72–72. 1 indexed citations

Botton, Mariana Rodrigues, Marina Curra, Marco Antônio Trevizani Martins, et al.. (2024). Genetic Variants Influence the Severity of Oral Mucositis in Pediatric Osteosarcoma Patients. Oral Diseases. 31(6). 1765–1775.

Jaeger, Mariane da Cunha, et al.. (2024). A Prognostic Methylation-Driven Two-Gene Signature in Medulloblastoma. Journal of Molecular Neuroscience. 74(2). 47–47.

Souza, Bárbara Kunzler, Thiago Santos Monteiro, Alice Laschuk Herlinger, et al.. (2023). Histone Methyltransferases G9a/Ehmt2 and GLP/Ehmt1 Are Associated with Cell Viability and Poorer Prognosis in Neuroblastoma and Ewing Sarcoma. International Journal of Molecular Sciences. 24(20). 15242–15242. 2 indexed citations

Jaeger, Mariane da Cunha, Caroline Brunetto de Farias, Carolina Nör, et al.. (2023). Targeting the epigenome of cancer stem cells in pediatric nervous system tumors. Molecular and Cellular Biochemistry. 478(10). 2241–2255. 7 indexed citations

Silveira, Felipe Martins, Marina Curra, Lauren Frenzel Schuch, et al.. (2021). Risk factors associated with the development of oral mucositis in pediatric oncology patients: Systematic review and meta‐analysis. Oral Diseases. 28(4). 1068–1084. 24 indexed citations

Nör, Carolina, André T. Brunetto, Algemir Lunardi Brunetto, et al.. (2020). Histone Deacetylase Inhibitors in Pediatric Brain Cancers: Biological Activities and Therapeutic Potential. Frontiers in Cell and Developmental Biology. 8. 546–546. 34 indexed citations

Souza, Bárbara Kunzler, André T. Brunetto, Caroline Brunetto de Farias, et al.. (2020). Expression and pharmacological inhibition of TrkB and EGFR in glioblastoma. Molecular Biology Reports. 47(9). 6817–6828. 6 indexed citations

10.

Souza, Bárbara Kunzler, Patrícia Luciana da Costa Lopez, Ana Lúcia Abujamra, et al.. (2018). Targeting Histone Deacetylase Activity to Arrest Cell Growth and Promote Neural Differentiation in Ewing Sarcoma. Molecular Neurobiology. 55(9). 7242–7258. 23 indexed citations

11.

Souza, Bárbara Kunzler, Lauro José Gregianin, André T. Brunetto, et al.. (2018). Epidermal Growth Factor Receptor Regulation of Ewing Sarcoma Cell Function. Oncology. 94(6). 383–393. 9 indexed citations

12.

Brunetto, André T., Lauro José Gregianin, Algemir Lunardi Brunetto, et al.. (2016). Combined Treatments with a Retinoid Receptor Agonist and Epigenetic Modulators in Human Neuroblastoma Cells. Molecular Neurobiology. 54(10). 7610–7619. 22 indexed citations

13.

Moreno, Víctor, David Olmos, Carlos Gomez‐Roca, et al.. (2014). Dose–Response Relationship in Phase I Clinical Trials: A European Drug Development Network (EDDN) Collaboration Study. Clinical Cancer Research. 20(22). 5663–5671. 14 indexed citations

14.

Molife, L. Rhoda, Emma Dean, Montserrat Blanco-Codesido, et al.. (2014). A Phase I, Dose-Escalation Study of the Multitargeted Receptor Tyrosine Kinase Inhibitor, Golvatinib, in Patients with Advanced Solid Tumors. Clinical Cancer Research. 20(24). 6284–6294. 23 indexed citations

15.

Brunetto, André T., Joo Ern Ang, Rohit Lal, et al.. (2013). First-in-human, Pharmacokinetic and Pharmacodynamic Phase I Study of Resminostat, an Oral Histone Deacetylase Inhibitor, in Patients with Advanced Solid Tumors. Clinical Cancer Research. 19(19). 5494–5504. 41 indexed citations

16.

Santos, Lucas Vieira dos, Fabrício Henrique Pereira De Souza, André T. Brunetto, André Deeke Sasse, & João Paulo da Silveira Nogueira Lima. (2012). Neurokinin-1 Receptor Antagonists for Chemotherapy-Induced Nausea and Vomiting: A Systematic Review. JNCI Journal of the National Cancer Institute. 104(17). 1280–1292. 97 indexed citations

17.

Olmos, David, Douglas S. Barker, Rohini Sharma, et al.. (2011). Phase I Study of GSK461364, a Specific and Competitive Polo-like Kinase 1 Inhibitor, in Patients with Advanced Solid Malignancies. Clinical Cancer Research. 17(10). 3420–3430. 134 indexed citations

18.

Brunetto, André T., Joo Ern Ang, David Olmos, et al.. (2010). A study of the pattern of hospital admissions in a specialist Phase I oncology trials unit: Unplanned admissions as an early indicator of patient attrition. European Journal of Cancer. 46(15). 2739–2745. 11 indexed citations

19.

Brunetto, André T., Debashis Sarker, Dionysis Papadatos-Pastos, et al.. (2010). A retrospective analysis of clinical outcome of patients with chemo-refractory metastatic breast cancer treated in a single institution phase I unit. British Journal of Cancer. 103(5). 607–612. 8 indexed citations

20.

Tolcher, Anthony W., Tami Yap, Ivy Fearen, et al.. (2009). A phase I study of MK-2206, an oral potent allosteric Akt inhibitor (Akti), in patients (pts) with advanced solid tumor (ST). Journal of Clinical Oncology. 27(15_suppl). 3503–3503. 54 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact